Evaluating disease control following belimumab treatment in patients with SLE enrolled in the US OBSErve studyJacob N Hunnicutt, Jolyon Fairburn-Beech, Mary Elizabeth Georgiou, Anna Richards, Yun Irene Gregan, Holly Quasny, Deven Chauhan
30 November 2022
Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquineCelline C Almeida-Brasil, John G Hanly, Murray Urowitz, Ann Elaine Clarke, Guillermo Ruiz-Irastorza, Caroline Gordon, Rosalind Ramsey-Goldman, Michelle A Petri, Ellen M Ginzler, Daniel J Wallace, Sang-Cheol Bae, Juanita Romero-Diaz, Mary-Anne Dooley, Christine Peschken, David IsenbergSee the full list of authors
17 November 2022
Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemicFrancesca S Cardwell, Susan J Elliott, Ricky Chin, Yvan St Pierre, May Y Choi, Murray B Urowitz, Guillermo Ruiz-Irastorza, Sasha Bernatsky, Daniel J Wallace, Michelle A Petri, Susan Manzi, Sang-Cheol Bae, Jung-Min Shin, Anselm Mak, Jiacai ChoSee the full list of authors
25 October 2022
Association of one-point glucocorticoid-free status with chronic damage and disease duration in systemic lupus erythematosus: a cross-sectional studyKen-ei Sada, Yu Katayama, Yosuke Asano, Keigo Hayashi, Yoshia Miyawaki, Keiji Ohashi, Eri Katsuyama, Takayuki Katsuyama, Mariko Takano-Narazaki, Yoshinori Matsumoto, Ryusuke Yoshimi, Yasuhiro Shimojima, Shigeru Ohno, Hiroshi Kajiyama, Kunihiro IchinoseSee the full list of authors
27 September 2022
Adverse pregnancy outcomes in women with systemic lupus erythematosus: can we improve predictions with machine learning?Melissa J Fazzari, Marta M Guerra, Jane Salmon, Mimi Y Kim
14 September 2022
Generation of evidence supporting the content validity of SF-36, FACIT-F, and LupusQoL, and novel patient-reported symptom items for use in patients with systemic lupus erythematosus (SLE) and SLE with lupus nephritis (LN)Rebecca Williams-Hall, Pamela Berry, Nicola Williamson, Melissa Barclay, Anna Roberts, Adam Gater, Chloe Tolley, Helena Bradley, Amy Ward, Elizabeth Hsia, Qing Zuraw, Patricia DeLong, Zahi Touma, Vibeke Strand
25 August 2022
Medium-term impact of the SARS-CoV-2 mRNA vaccine against disease activity in patients with systemic lupus erythematosusTsuneyasu Yoshida, Hideaki Tsuji, Akira Onishi, Yudai Takase, Mirei Shirakashi, Hideo Onizawa, Ryosuke Hiwa, Koji Kitagori, Shuji Akizuki, Ran Nakashima, Masao Tanaka, Hajime Yoshifuji, Akio Morinobu
12 August 2022
Intermittent and Persistent Type 2 lupus: patient perspectives on two distinct patterns of Type 2 SLE symptomsAmanda M Eudy, Jennifer L Rogers, Amy Corneli, Kevin McKenna, Mithu Maheswaranathan, David S Pisetsky, Lisa G Criscione-Schreiber, Jayanth Doss, Rebecca E Sadun, Kai Sun, Megan E B Clowse
5 August 2022
Patient and healthcare team recommended medication adherence strategies for hydroxychloroquine: results of a qualitative study informing intervention developmentShivani Garg, Betty Chewning, David Gazeley, Shelby Gomez, Noah Kaitz, Amanda C Weber, Ann Rosenthal, Christie Bartels
1 August 2022
Immunogenicity of the third and fourth BNT162b2 mRNA COVID-19 boosters and factors associated with immune response in patients with SLE and rheumatoid arthritisTheerada Assawasaksakul, Seelwan Sathitratanacheewin, Preeyaporn Vichaiwattana, Nasamon Wanlapakorn, Yong Poovorawan, Yingyos Avihingsanon, Nawaporn Assawasaksakul, Wonngarm Kittanamongkolchai
28 July 2022